Skip to main content
European Commission logo
Coronavirus Global R&I Collaboration Portal


Members (3)

From across Europe and beyond, and from a variety of backgrounds, our members share many common goals. Our members’ diversity, expertise and openness to collaborate is our strength. Search our members list here. Filter using our search options. All members are encouraged to network and develop as a community that fosters collaboration. Find your match, share, engage and complement expertise.

Showing 1-3 of 3 members.

Komesli Yelda

Higher education
Home country
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Medical and health sciences
Specialisation and expertise

I am working in nano drug design field in Altınbaş University , Faculty of Pharmacy.

I have also 7 years of drug development experience in ARGEFAR R&D Center in EGE University.

My goal is to use nanoformulations that we developed for enhancing bioavailability. I also use these formulations for fluorescent imaging and to diminish side effects. I have previous experience in olmesartan medoxomil SMEDDS and Dexamethasone SNEDDS ophtalmic gtt. I also aim to design new formulations with this technology for miRNA's and vaccines.

I am looking forward to meeting with possible partners for nano drug development projects, who has bioavailability, side effect and drug targeting problems. Then we can provide solutions and publish our findings.

Eligibility criteria Researchers in R&D fields from universities, public or private sector.

Targeted gene silencing drugs project The University of Texas MD Anderson Cancer Center Prof.Dr. Bülent Özpolat

Anti-Cancer triple hit: MSLN, MYCN and Telomerase  targeting RNAs EuroNanoMed III 2021 Call (1st Phase) TÜBİTAK 1071, TÜBİTAK PROJECT, Director: YELDA KOMESLİ, Researcher: FATMA TUBA GÖZET, , 17/02/2021 ( Ongoing) (INTERNATIONAL)

Ege University Scientific Research Project (BAP), 2000, Master Thesis Project, Ph.D.Yelda Komesli, Prof.Dr. Levent                 Kirilmaz,  Studies on Responsive Drug Release Systems 99, 99 / ECZ / 014

Ege University Scientific Research Research Project (BAP), 2015, PhD Thesis Project, Prof.Dr. Ercüment Karasulu,

Exp. Pharm. Yelda Komesli ’Preparation of self-microemulsion drug delivery system (smedds) containing Olmesartan Medoxomil, In Vitro Quality Control, In Vivo Pharmacokinetics (by fluorescent Labeling) and Pharmacodynamic Evaluation 15’, 15-ECZ-014

Aliye Üster Foundation Project Achievement Scholarship, Preparation of Self-Emulsifying Drug Release System (SMEDDS) Containing Olmesartan Medoxomil, In Vitro Quality Control, In Vivo Pharmacokinetics (Via Fluorescent Marking) and Pharmacodynamic Evaluation, 2016

TÜBİTAK 3501 Career Development Project  Development of New Formulation of Olmesartan Medoxomil Containing Self-Emulsifying Microemulsion Drug Release System (SMEDDS) for Pediatric, Geriatric and Adult Patients, Evaluation of Pharmacokinetic Profile and Celiac-Like Enteropathy Side Effect. “C ‘’ score was given and the appropriation was not given. The appeal was rejected. 2018.

TÜBİTAK 1001 The Evaluation of the Pharmacokinetic Profile and Celiac-Like Side Effects of Self Microemulsifying Drug Delivery System (SMEDDS) and tablet of Olmesartan Medoxomil and Development of the Alternative Formulations for the Pediatric, Geriatric, and Adult Patients. 2019  (in the application process)

Altınbaş University BAP Project  “Ocular Targeting with Nanoparticular Lipid Based Systems as an Alternative of Intravitreal Injection”

Quantitative Analysis of Phenolic Compounds in Sage and Hawthorn Capsules by HPLC-UV Method, Scientific research project supported by Higher Education Institutions, Researcher: KOMESLİ YELDA, Director: GÖZET FATMA TUBA, , 15/05/2020 (Continuing) (ULUSAL) Altınbaş University BAP Project

1512 -Technoventure Capital Support Program (BiGG) Project titled "Enhancing Bioavailability of Olmesartan with Microemulsified Drug Release Systems (AREGEMENT)" Executive Yelda KOMESLİ (In Evaluation Phase)


English, Turkish


Government & public sector
Home country
Type of research activities
Applied research, Basic research
Fields of research
Psychology and cognitive sciences, Economics and Business, Education, Sociology, Law, Political science, Social and economic geography, Media and communications, Other social sciences, Natural sciences, Engineering and technology, Medical and health sciences, Agricultural and veterinary sciences, Humanities and the arts
Specialisation and expertise

Turkish Academy of Sciences (TÜBA) has been helping and promoting a Sustainable and Resilient Recovery from COVID-19, as a national science academy of Turkey. TÜBA has also conducted various scientific research from the beginning of the global outbreak. Honor, Principal, and Associate members of TÜBA have taken place in the Scientific Council of Turkey for struggling with COVID-19 and in many different projects related to this pandemic. The main principle of TÜBA is multi-disciplinary and thematic methods in scientific and academic works. To do that, it has promoted the publishing of many generic works in various scientific fields. While we are aware of the global damage of this pandemic, TÜBA started its scientific works for informing people with scientific knowledge in this digitally polluted era. Misinformation in social media and similar channels has negatively affected the struggle with the COVID-19 Pandemic. At this point, TÜBA helped to contribute to reliable data flow through scientific reports, books, and information sharing through social media accounts. Firstly, TÜBA published “The Assessment Report on COVID-19 Global Outbreak” on 17 April 2020. The report has been updated six times periodically in Turkish. The latest version of the report has been translated, published in English, and shared with partner academies without losing time. Transparency and reaching the information have been priorities for our Academy. Secondly, the book namely "Reflections on the Pandemic in the Future of the World" has been published in Turkish and English as the first Post-Corona book in Turkey. There are projections for a wide range of post-epidemic periods, from healthcare to education, information technologies to political science, economics to international relations, trade to Philosophy, artificial intelligence studies, sociological analysis, Environment and agriculture, space, and polar studies. Thirdly, “TÜBA Report on Climate Change and Public Health in Turkey” has been published in Turkish and English. It has comprehensively analyzed the situation of Turkey and in vital areas such as Sustainable Development, Climate Change, and Public Health. Fourthly, “TÜBA COVID 19 – Global Outbreak: Report on Judicial Changes and Interactions” has been published in Turkish and English. The report analyses the effects of the COVID–19 Outbreak on Constitutional Law, Administrative Law, Penal Law, Tax Law, International Law, Civil Law, Commercial Law, Labor and Social Security Law, Enforcement and Bankruptcy Law in five chapters. All these reports and books were prepared with help of the following scientific experts including experts from TÜBA, Working Groups of Academy such as Cancer, Food and Nutrition and Sustainable Development, Finance and Environment Working Group, TÜBA Young Academy, and Coronavirus Scientific Committee. Scientists and academicians worked together on these reports for ensuring to receive clear and accurate information about the pandemic in Turkey.

Turkish, English
The portal is now open.

Join this community of researchers, publish your member profile and team up for new collaboration opportunities.

Become a member